Source file signed link, expires in 15 minutes
Extracted text 6
Page 1 OCR 0.924
Kami yang bertanda tangan dibawah ini : 1. Nama Alamat kantor Alamat domisili sesuai KTP SURAT PERNYATAAN DIREKSI TENTANG TANGGUNG JAWAB ATAS LAPORAN KEUANGAN KONSOLIDASIAN UNTUK TAHUN YANG BERAKHIR PADA TANGGAL 30 JUNI 2024 PT UBC MEDICAL INDONESIA Tbk DAN ENTITAS ANAK/ STATEMENT OF DIRECTOR'S REGARDING RESPONSIBILITY FOR CONSOLIDATED FINANGIAL STATEMENTS FOR THE YEARS ENDED JUNE 30, 2024 PT UBC MEDICAL INDONESIA Tbk AND SUBSIDIARY Franciscus Xaverius Yoshua Raintjung Jl. Rawagelam V L, No Kav 11-13, Kel. Jatinegara Kec. Cakung Jakarta Timur, Jakarta GG. Trikora II No.15 RT 005/RW 006, Duri Utara, Tambora Nomor telepon 081804949499 Jabatan Direktur Utama/ President Director Nama Marcella Angelin Alamat kantor Alamat domisili sesuai KTP Nomor t Jabatan Jl. Rawagelam V L. No Kav 11-13, Kel. Jatinegara Kec. Cakung Jakarta Timur, Jakarta Jl. Hemat 2 No.42, RT 008/RW 003, Jelembar, Grogol Petamburan 08159161929 Direktur/ Director telepon Menyatakan bahwa : As We, the undersigned : Name Office address : Domicile as stated in ID card Phone number Position Name Office address : Domicile as stated in ID card Phone number Position State that : We are responsible for the preparation and penyajian laporan konsolidasian Perusahaan, keuangan 2 “Laporan keuangan konsolidasian Perusahaan telah disusun dan disajikan sesuai dengan Standar Akuntansi Keuangan di Indonesia, Semua informasi dalam laporan keuangan konsolidasian Perusahaan telah dimuat secara lengkap dan benar,dan b. Laporan keuangan konsolidasian tidak mengandung informasi atau fakta material yang tidak benar, dan tidak menghilangkan informasi atau fakta material: 4. Kami bertanggung jawab atas sistem pengendalian intern dalam Perusahaan. Demikian pernyataan ini dibuat dengan sebenarnya. Kami bertanggung jawab atas penyusunan dan 1. presentation of the consolidated financial statements of the company, 2. The consolidated financial statements of the company have been prepared and presented in accordance with the Indonesian Financial Accounting Standards: All information — contained in the consolidated financial statements of the company are complete and correci,and b. The consolidated financial statements of the company do not contain misleading material information or facts, and do not omit material information and facts: 3. a 4. We are responsible for the Company internal control system. This statement letter is made truthfully. Jakarta, 9 Desember 2024/ Jakarta, December 9, 2024 Direktur/ Director 'BIDDAMX065977251 Franciscus Xaverius Yoshua Rartiyuriy marcella Angelin
Page 2 OCR 0.846
PT UBC MEDICAL INDONESIA Tbk LAPORAN POSISI KEUANGAN KONSOLIDASIAN Per 30 Juni 2024 dan 31 Desember 2023 (Disajikan dalam Rupiah, kecuali dinyatakan lain) PT UBC MEDICAL INDONESIA Tbk CONSOLIDATED STATEMENT OF FINANCIAL POSITION As of June 30, 2024 and December 31, 2023 (Expressed in Rupiah, unless otherwise staled) Catatan) 30 Juni 2024 31 Desember 2023 Note June 30, 2024 December 31, 2023 ASET ASSETS Aset Lancar Current Assets Kas dan setara kas 22,2,21,2h,4,32 2.152.004.684 3.616.880.083 Cash and cash oguivalents Piutang usaha Account receivablos - nett Pihak ketiga 2,29,5,32 30.946.639.952 33.303.916.784 Third partios Pihak berelasi 24,29,21,5,30a,32 22.330.650 22.330.650 Related parlios Persediaan 2,6 58.759.647.982 55.391.701471 Inventories Pajak dibayar dimuka 2t13a 16.501.148.630 9.202.912.338 Prepaid tax Biaya dibayar dimuka 2,7 487.844.678 202.539.776 Prepaid expense Uang muka 2x7 8.278.180.702 9.155.478.746 Advance payment Jumlah Aset Lancar 117.147.797.278 110.395.759.848: Total Current Assets Aset Tidak Lancar Non Current Assets Piutang lain-lain 29,30 - - Other receivables Aset tetap - bersih 2,8 3.271.600.868 35.549.810.324 Fixes assets - nett Investasi pada entitas asosiasi - - Invesmenis in associates Aset hak guna usaha 2912 554.598.933 554.598.933 Right of use assets 'Aset pajak tangguhan - bersih 213d 2.733.624.916 2.733.624.916 Deferred tax assets - not Pengembangan produk 8.732.568.740 10.142.938.228 Product development 'Aset lain-lain tidak lancar 2n,11,32 23.000.000 410.500.000 Other non current assets Jumlah Aset Tidak Lancar 45.315.383.457 49.391.472.401 Total Non Current Assets JUMLAH ASET 162.6: 35 TOTAL ASSETS Catatan atas laporan keuangan merupakan bagian yang tidak terpisahkan dari laporan keuangan The accompanying notes Irom an intogral part of these financial statements adas
Page 3 OCR 0.873
PT UBC MEDICAL INDONESIA Tbk LAPORAN POSISI KEUANGAN KONSOLIDASIAN Per 30 Juni 2024 dan 31 Desember 2023 (Disajikan dalam Rupiah, kecuali dinyatakan lain) Catatan/ Note PT UBC MEDICAL INDONESIA Tbk 'STATEMENT OF FINANGIAL POSITION As of June 30, 2024 and December 31, 2023 (Exoressod in Rupiah, unless otherwise stated) 31 Desember 2023 December 31, 2023 30 Juni 2024 June 30, 2024 LIABILITAS DAN EKUITAS LIABILITAS Liabilitas Jangka Pendek Utang bank 20 Utang usaha Pihak ketiga Pihak berelasi Utang lain-lain Pihak ketiga Pihak berelasi Pinjaman Pihak ketiga Pihak berelasi Utang pajak Uang muka pelanggan Beban masih harus dibayar Liabilitas jangka panjang yang akan jatuh tempo dalam satu tahun Utang pembiayaan konsumen Utang sewa hak guna Jumlah Liabilitas Jangka Pendek 2e,2h,2p,14,32 2e,2i,2p,14,30d,32 213b 2r16,32 17,32 18,32 29,19 bilitas Jangka Panjang Utang jangka panjang-setelah dikurangi bagian yang jatuh tempo kurang dari satu tahun : Utang pembiayaan konsumen Utang sewa hak guna Utang pihak berelasi Liabilitas imbalan kerja Jumlah Liabilitas Jangka Panjang 18,32 2300 2u.22 JUMLAH LIABILITAS EKUITAS Modal saham - nilai nominal Rp40 pada 31 Desember 2023 dan Rp11.482.000 per31 Desember 2022 dan 2021 Modal dasar sebesar 3.512.482.000 pada 31 Desember 2023, 12.290 dan 1.000 lembar saham per 31 Desember 2022 dan 2021 Modal ditempatkan dan disetor penuh sebesar 1.625.000.000, 4.097 dan 1.000 lembar saham per 31 Desember 2023 2022 dan 2021 28 Tambahan modal disetor Selisih kurs modal disetor Saldo laba Telah ditentukan penggunaannya Belum ditentukan penggunaannya Penghasilan komprehensif lain Kepentingan non-pengendali JUMLAH EKUITAS JUMLAH LIABILITAS DAN EKUITAS Catatan atas laporan keuangan merupakan bagian yang tidak terpisahkan dari laporan keuangan 32.920-201.310 LIABILITIES AND EGUITY LIABILITIES Current Liabilities Loans Payable Account payables Third partios Related parties Other Payable Third parties Related parties Loan to Third parties Related parties Taxes payable 20.386.902.103 21.321.882.881 37.820.614.553 37.248.380.835 - 1.225.454.373 103.195.844 435.000.000 412.731.845 127.577.035 230.192.536 7.159.214.156 'Advances from customers 614.213.251 2.900.757.469 'Acorued expenses Current maturity of long term Hiabilitios: 452.849.946 368.191.317 Consumer finance payable 229.438.530 Lease liabilitios T2.015.896.546 Total Current Liabilities Lang Term Liabilitios Long term Niabilties - net of Current maturities - 296.405.229 Consumer finance payablo 342.520.450 342.520.450 Lease liabiftios 31.381.545.856 18.863.078.240 Due to related partios 1.246.135.004 20.748.138.923 Employee benefit habilities Total Long Term Liabilities 1.246.135.004 TOTAL LIABILITIES 92-764.035.469 EGUITY Capital stock - par valve Rp40 in December 31, 2023 and Rp11.432,000 in December 31, 2022 and 2021 “Authorized Capital 3,512,482,000 in December 31, 2023, 12,290 and 1,000 sharos in Docamber 31, 2022 and 2021 Issued and fully paid up capital in 1,625,000,000, 4,097 and 1,000 shares in December 31, 2023 2022 and 2021 'Addition of paid in capital Foreign exchange difirence in 46.836.904.000 18.163.096.000 5.000.000.000 587.250.000 537.250.000 paid -up capital Retained earnings 200.000.000 200.000.000 Appropriated 3.836.822.206 2.069.182.324 Unappropriated (283.318.182) - 283.318.182 Other comprehensive income 69.290.754.024 67.523.114142 86.793 82.638 Non-controlling interests 7.523.196.780 TOTAL E@UITY TOTAL LIABILITIES AND EGUITY Jakarta, 9 Desember 2 Direktur The accompanying notes rom an integral part of these financial statements -Ab-
Page 4 OCR 0.872
PT UBC MEDICAL INDONESIA Tbk LAPORAN LABA RUGI DAN PENGHASILAN KOMPREHENSIF LAIN KONSOLIDASIAN Untuk Tahun Yang Berakhir Pada Tanggal 30 Juni 2024 dan 2023 (Disajikan dalam Rupiah, kecuali dinyatakan lain) 30 Juni 2024 June 30, 2024 PT UBC MEDICAL INDONESIA Tbk CONSOLIDATED STATEMENT OF PROFIT OR LOSS For (AND OTHER COMPREHENSIVE INCOME The Years Ended June 30, 2024 and 2023 (Expressed in Rupiah, unless otherwise stated) 30 Juni 2023 June 30, 2023 Catatan! Note PENDAPATAN 25.2x,25,34 BEBAN POKOK PENDAPATAN 25,2x,26,34 LABA BRUTO BEBAN OPERASIONAL Beban penjualan dan pemasaran 2521 Beban umum dan adminstrasi 25.28 JUMLAH BEBAN OPERASIONAL LABA USAHA PENDAPATAN (BEBAN) LAIN-LAIN Bagian laba perusahaan asosiasi 25.29 Laba pelepasan penyertaan entitas asosiasi — 25,29 Laba penjualan aset 25.29 Pendapatan keuangan 25.29 Biaya keuangan 25,29 Laba (rugi) selisih kurs 25,29 Beban cadangan penyisihan persediaan 25,29 Beban penghapusan persediaan 25,29 Pemulihan (penyisihan) penurunan nilai piutang 25.29 Pendapatan (beban) lain-lain 25.29 JUMLAH PENDAPATAN (BEBAN) LAIN-LAIN LABA SEBELUM PAJAK MANFAAT (BEBAN) PAJAK PENGHASILAN Kini Tangguhan JUMLAH MANFAAT (BEBAN) PAJAK PENGHASILAN LABA TAHUN BERJALAN PENGHASILAN (RUGI) KOMPREHENSIF LAIN Pengukuran kembali imbalan pasca kerja Pajak penghasilan yang berkaitan dengan komponen lainnya pendapatan komprehensif LABA KOMPREHENSIF TAHUN BERJALAN Laba bersih yang dapat diatribusikan kepada: Pemilik entitas induk Kepentingan non pengendali LABA PER SAHAM Catatan atas laporan keuangan merupakan bagian yang tidak terpisahkan dari laporan keuangan 64.534.441.378 (36.923.672.318) z 11.759.351.463 —122516.085.407 24.336.036.930 3.274.732.130 4.775.939 (1.491.152.953) (1.155.918.032) (1.507.088.093) 37 1.767.639.882 4155 1.767.644.037 1,09077 36.460.720.161 (24.770.225.378, 1.690.500.783 1.274.559.218 1.026.798.892 2.301.358.110 (10.610.257.327) 291.861 (1.105.813.178) 525.681.607 149.296.364 (430.543.346) 11.041.400.673) 001200673) (11-041.400.673) (11.041.383.311) - 17.362 ——41.041.400.673 (9,50781) REVENUE COST OF REVENUE GROSS PROFIT OPERATING EXPENSES Selling and marketing Genoral and administrative TOTAL OPERATING EXPENSES OPERATING PROFIT OTHER INCOME (EXPENSES) Gain on associate companies Gain on disposal in associate companies Gain on sale of fixed assets Finance income Finance cost (Loss) gain of foreign exchange Allowance for impairment losses of inventories Inventories writo off oxpensos Recovery (allowance) for impairment of account receivables Miscellaneous TOTAL OTHER INCOME (EXPENSES) PROFIT BECOME INCOME TAX INCOME TAX (EXPENSES) BENEFIT Current Deferred TOTAL INCOME TAX (EXPENSES) BENEFIT PROFIT FOR THE YEAR OTHER COMPREHENSIVE INCOME (EXPENSES) Remeasurement of post-omployment benefits Income tax relating to components of other comprehensive income 'COMPREHENSIVE INCOME CURRENT YEAR Net income attributable to: Owners of the parent Non controlling interests EARNING PER SHARE Jakarta, 9 Desember 2024, Direktur The accompanying notes from an integral part of these financial statements.
Page 5 OCR 0.233
Slvawayeis erueu asoy jo ed eiBony ve woy sajou Buuedwoooe cu. LI OROS769 ebiwenan uesodeg ep uenyyesidunn yeph BueA uolbeg nyedruaw uebuenay uesodej sere ueje1ea 202 08 oung yo se sourjeg awoou ansuoyadwoo sawo (poad og 01 oto (endeo upred reuompov p202 "1 Arenuer jo se soup 6202 02 sung yo se sourjeg woou awsuayardua sopo powad og 01 oa jender prod evonppy 2102 Amnuer yo se oouejeg p20z '0e cun popua SuCOA Dul 104 TN OPT 06F85 Teras Te0rsL 6703 Gor en orat Dgoroo-o0t Teraiene Doo ose1ea 00000 00053 reog junr os sod opies 3 2 ey ysusypudwoy urtedepuag 12010911944 sar z0eree0rLaL, 288/6R019L, - - uogobog apouad ws1og ege1 oo0rgeorca1ei O00ge0e9181 ooo9eoeo1s1 Jorosip (epow veypawe o21-001-o9e'8p 2920 2nisLoooe'er rerusIedo O00'00'0oz (evsiceez) Oov0sz'1e5 o00-yos'see'sp y202 uenuer 1 2od opies Terserotrar Toozes Dersenanyar Trascortoeoi Tara 7 DOO UE. TS D00os BER 202 tunr or s0d opies & 2 2 2 1 pSuayasdwog upjedepuag (cumooruwari) (aer) (weeeewow) —— Gieesewoti) - - uojobog apoved wssog 8901 . Inresprepow ueyegue1. MT BOS OLPLP 022-685 LogBe86DpLh sngrozoez uirrergh Oov0sz1e5 000-p08-se8”8 £20z yenuer LJad opres Semua penang Bare Pena pena aa Inn uaee Au ROSE “TN 10903 opres Ierunxg weunp — /ekuuecunBBuad — jekuupounBBuad — asuayardwod Sako uo — couaraypabunyora — JueueS IepOW —JUINEO 1vo9-uo9 ueymuanp wnjag — uenyuoyp uoja1 Jaw ss01 jevanyoy "jasa mopuobuag SOURg peuaN | Para OpIES Tekuure pereinwnooy Jonasip lepom uoN upBupuaday psuayaidwoy eliay uejegui sung usias umodepuag Sue euenay @s1waujo ssajun 'yegdny uj pessoudxa) ALINOI NI SONYHI JO SANIMILVAS GL VISINOGNI IVOIGEW DGN Ld 1Gny iseinunyy (ui ve) moon 'ypiinsi werep venlesia) sz0z ng oc IeBiBue: epeg apeiog Buex unye1 Imun SWUINYIS NYHVANSd NYSOAYI MAL VISBNOANI TVOIASM Dgn Ld
Page 6 OCR 0.883
PT UBC MEDICAL INDONESIA Tbk LAPORAN ARUS KAS KONSOLIDASIAN Untuk Tahun Yang Berakhir Pada Tanggal 30 Juni 2024 dan 2023 (Disajikan dalam Rupiah, kecual dinyatakan lain) PT UBC MEDICAL INDONESIA Tbk CONSOLIDATED STATEMENTS OF CASH FLOW For The Years Ended June 30, 2024 and 2023 (Exprossed in Rupiah, unless otherwise statod) Catatan! 30 Juni 2024 30 Juni 2023 Note June 30, 2024 June 30, 2023 'Arus Kas dari Aktivitas Operasi: Cashflow from Operating Activities: Penerimaan dari pelanggan 59.962.696.590 34.510.090.363 Cash Received from customers Pembayaran kepada pemasok Cash paid to supplier and dan pihak ketiga (40.067.541.440) —— (25.257.976.154) Third parties Pembayaran kepada karyawan (2.286.544.218) (8.925.337.343) Cash paid to employees Pembayaran untuk beban usaha (17.365.087.649) —(24.086.516.820) Cash paid for operating expenses Pembayaran pajak penghasilan (8.013.081.481) Cash paid for incomno tax Penerimaan bunga 4.775.939 291.861 Cash received from Interest Pembayaran bunga dan provisi (1.491.152.953) (1.105.893.178) Cash paid for interest and provision Penerimaan (pembayaran) Other business kegiatan usaha lainnya (20.711.080) (60.359.455) receipts (payments) Arus Kas Neto yang Diperoleh dari Net Cash Flows Provided by (Digunakan untuk) Aktivitas Operasi (9.276.646.292) 19.925.700.726) (Use in) Operating Activities 'Arus Kas dari Aktivitas Investasi: Pelepasan penyertaan pada entitas asosiasi Penyertaan pada entitas asosiasi Perolehan aset tetap (8.180.165.238) Hasil penjualan aset tetap Perolehan aset hak guna Perolehan aset Isin-lain tidak lancar Arus Kas Neto Dipergunakan untuk Cashflow from Investment Activities: 5.952.032.075 Disposal investment In Shares of associate Investment in shares of associate (9.600.061.573) AAcguisitions of fixed assets 18.769.040 Procoeds from disposal of fixed assets 'Acguisitions of right use assots 343.532.662 Acguisitions of other non current assets Net Cash Flows Used in “Aktivitas Investasi (3.180.165.238) (9.972.793.120) Investing Activities Arus Kas dari Aktivitas Pendanaan: Pencairan pinjaman bank (932.980.728) Penambahan modal disetor Penerimaan (pembayaran) utang pada: Cashflow From Financing Activities: (4.313.226.100) Drawdown of bank loans 'Addition of paid in capital Receipts (Payments) loan to: Pihak berelasi 12.136.663.460 35.025.809.315 Related partios Pihak ketiga Third parties Pembayaran sewa pembiayaan (211.746.601 (785.105.830, Payment of lease payable Arus Kas Neto yang Diperoleh dari Aktivitas Pendanaan 10.991.936.131 Kenaikan (penurunan) Bersih Kas dan Setara Kas (1.464.875.399) Dampak Perubahan Kurs Dan Setara Kas Kas dan Setara Kas pada awal periode 3.616.880.083 Kas dan Setara Kas Pada Akhir Periode 26,20,21,2h,4,32 Kas dan Setara Kas terdiri dari: Kas 62.861.480 Bank 2.089.143.204 Jumlah 2.152.004.684 Catatan atas laporan keuangan merupakan bagian yang tidak terpisahkan dari laporan keuangan ae Net Cash Flows Provided by 29.927.477.385 Financing Activities Net Increase (Decrease) Cash 28.983.539 and Cash Eguivalents Exchange Rate On Cash And Cash Eguivalents Cash and Cash Eguivalents 827.526.167 at Beginning of Period Cash and Cash Eguivalents at Ending of Period Cash and Cash Eguivalents consist of: 48.000.000 Cash on hand 1.549.770.751 Cash in banks 70.151 Total The accompanying notes from an integral part of those financial statements
Names mentioned 3 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.